Abstract
Purpose: Early predictors of diabetic complications may aid in the prevention and/or management of these complications. The aim of this cross-sectional study was to determine the predictive value of retinopathy for the presence of other diabetic complications.Methods: The population studied comprised 648 patients with diabetes mellitus assessed by our service. There were 210 patients (32.4%) with insulin-dependent diabetes mellitus (IDDM), and 438 patients (67.6%) with non-insulin-dependent diabetes mellitus (NIDDM).Results: Univariate analyses revealed that retinopathy significantly predicted the presence of neuropathy (odds ratio [OR] = 2.23; 95% confidence interval [CI] = 1.56–3.18; p < 0.00l), nephropathy (OR = 5.68; 95% CI = 3.06–10.62; p < 0.00l), and cerebrovascular disease (OR = 6.6; 95% CI = 1.16–67.21; p = 0.0239) in the total group. Similar associations were observed both in subjects with IDDM and NIDDM. The associations between retinopathyseverity level and the prevalence rate of nephropathy were significant in the total group (p = 0.0001), in patients with IDDM (p = 0.0113), and in patients with NIDDM (p = 0.01). In patients with mild to moderate non-proliferative retinopathy (NPDR), nephropathy was present in 17.2% of patients with IDDM, and in 11.4% of patients with NIDDM. In patients with severe NPDR, nephropathy was present in 23.3% in patients with IDDM, and in 11.8% of patients with NIDDM. In patients with proliferative retinopathy (PDR), nephropathy was present in 50% in patients with IDDM, and in 45.5% in patients with NIDDM. In multivariate logistic regression analyses, nephropathy was the only significant complication to be independently associated with retinopathy in patients with IDDM (OR = 8.02; 95% CI = 1.95–33), and in patients with NIDDM (OR = 2.48;95% CI = 1.02–6.03).Conclusions: Retinopathy, especially the presence of PDR, is an independent predictor for nephropathy. The predictive value of retinopathy for nephropathy is stronger in patients with IDDM than in those with NIDDM. Ophthalmologists should refer patients with retinopathy for regular medical evaluations.
Similar content being viewed by others
References
Weir GC, Mathan DM, Singer DE. Standards of care for diabetes. Diabetes Care 1994; 17: 1514-1522.
Klein R, Moss SE. Visual impairment and diabetes. In: Alberti KGMM, De Fronzo RA, Keen H, Zimmet P, eds. International Textbook of Diabetes Mellitus. Vol. 2. Chichester: Wiley, 1992; 1373-1384.
The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings: DRS report number 8. Ophthalmology 1981; 88: 583-600.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early teatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985; 103: 1796-1806.
Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-661.
Parving H-H, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, et al: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 1988; 296: 156-160.
Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996; 19: 1243-1248.
Falkenberg M, Finnström K. Associations with retinopathy in type 2 diabetes: A population-based study in a Swedish rural area. Diabetic Med 1994; 11: 843-849.
Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 1998; 31: 947-953.
Villar G, Garcia Y, Goicolea I, Vazquez JA. Determinants of development of microalbuminuria in normotensive patients with type 1 and type 2 diabetes. Diabetes Metab 1999; 25: 246-254.
Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993; 100: 862-867.
Klein R, Moss SE, Klein BEK: Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy. Ophthalmology 1993; 100: 1140-1146.
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824.
Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994; 17: 1172-1177.
Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton U, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study Cohort. Diabetes Care 1999; 22: 1479-1486.
Petitti DB, Bhatt H. Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke 1995; 26: 593-596.
Hämäläinen H, Rönnemaa T, Halonen J-P, Toikka T. Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: A population-based 7-year follow-up study. J Intern Med 1999; 246: 97-103.
Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 1995; 18: 509-516.
Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care 1996; 19: 704-709.
Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999; 117: 1487-1495.
Ito H, Harano Y, Suzuki M, Hattori Y, Takeuchi M, Inada H, et al. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM). Diabetes 1996; 45(Suppl.): S19-S23.
American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 1988; 21: S23-S31.
Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics. EDTRS report number 7. Ophthalmology 1991; 98: 741-756.
American Diabetes Association. Diabetic nephropathy (Position Statement). Diabetes Care 1999; 22(Suppl. 1): S66-S69.
Guerrero-Romero F, Rodriguez-Moran M. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. Stroke 1999; 30: 1787-1791.
Decker T, Feldi-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 1989; 32: 219-226.
Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, et al. Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989; 32: 92-102.
Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 1985; 82: 2513-2517.
Yasuda H, Dyck PJ. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987; 37: 20-28.
Bell DSH: Stroke in the diabetic patient. Diabetes Care 1994; 17: 213-219.
Aronson SM. Intercranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 1973; 23: 1983-1996.
Alex M, Baron EK, Goldenberg S Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation. 1962; 25: 663-673.
Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6: 87-91.
Sittonen OI, Niskanen LK, Laakso M, Sutonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. Diabetes Care 1983; 16: 6-20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Asrar, A.M.A., Al-Rubeaan, K.A., Al-Amro, S.A. et al. Retinopathy as a predictor of other diabetic complications. Int Ophthalmol 24, 1–11 (2001). https://doi.org/10.1023/A:1014409829614
Issue Date:
DOI: https://doi.org/10.1023/A:1014409829614